Plus Therapeutics Inc (PSTV) — Cash Flow Quality Index

Latest as of June 2025: -1.13x

Plus Therapeutics Inc (PSTV) has a Cash Flow Quality Index of -1.13x as of June 2025. Operating cash flow of $-5.80 Million is below net income of $5.15 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Plus Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-1.13x

Operating CF / Net Income

Operating Cash Flow

$-5.80 Million

USD

Net Income

$5.15 Million

USD

Data as of

Jun 2025

Most recent filing

Annual Cash Flow Quality Index for Plus Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Plus Therapeutics Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.